User profiles for L Tarraga

Lluís Tàrraga

Fundaciò ACE
Verified email at fundacioace.org
Cited by 10392

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

…, WA Kukull, AM Koivisto, A Lynch, L Tarraga… - Nature …, 2019 - nature.com
Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …

Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

…, I Henández, RC Barber, M Scherer, L Tarraga… - Nature …, 2017 - nature.com
We identified rare coding variants associated with Alzheimer's disease in a three-stage case–control
study of 85,133 subjects. In stage 1, we genotyped 34,174 samples using a whole-…

Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP

…, P Martínez-Lage, J Masdeu, L Molina-Porcel… - Neurobiology of …, 2010 - Elsevier
… Neuroimaging features included atrophy in both parietal regions (R>L) and SPECT
revealed hypoperfusion in temporoparietal regions (R>L). This variant alters a non-conserved …

[HTML][HTML] The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease

…, E Vázquez, L Tárraga… - Genome medicine, 2011 - Springer
Background In order to identify novel loci associated with Alzheimer's disease (AD), we
conducted a genome-wide association study (GWAS) in the Spanish population. Methods We …

Neuropsychiatric inventory questionnaire (NPI-Q): Spanish validation of an abridged form of the Neuropsychiatric Inventory (NPI)

M Boada, JC Cejudo, L Tarraga, OL López… - Neurologia (Barcelona …, 2002 - europepmc.org
Background The Neuropsychiatric Inventory (NPI) is a validated clinical instrument for the
evaluation of psychopathology in dementia. Objective To validate a brief questionnaire form of …

Amyloid-targeted therapeutics in Alzheimer's disease: use of human albumin in plasma exchange as a novel approach for Abeta mobilization.

…, J Olazarán, I Roca, G Cuberas, L Tárraga… - Drug news & …, 2009 - europepmc.org
A clinical investigation program was carried out to replace endogenous albumin of patients
with mild to moderate Alzheimer's disease (AD) with 5% Human Albumin Grifols (R) through …

[HTML][HTML] Efficacy and safety of plasma exchange with 5% albumin to modify cerebrospinal fluid and plasma amyloid-β concentrations and cognition outcomes in …

…, A Lafuente, L Tárraga, L Núñez… - Journal of …, 2017 - content.iospress.com
Methods: In a multicenter, randomized, patient-and rater-blind, controlled, parallel-group,
phase II study, 42 AD patients were assigned (1: 1) to PE treatment or control (sham) groups. …

Genetic risk for schizophrenia and psychosis in Alzheimer disease

…, I Hernandez, S Moreno-Grau, L Tárraga… - Molecular …, 2018 - nature.com
Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent
in Alzheimer disease (AD), affecting~ 40 to 60% of individuals with AD (AD with psychosis (…

Genome-wide association identifies the first risk loci for psychosis in Alzheimer disease

…, R Sims, I Hernandez, S Moreno-Grau, L Tárraga… - Molecular …, 2021 - nature.com
Psychotic symptoms, defined as the occurrence of delusions or hallucinations, are frequent
in Alzheimer disease (AD with psychosis, AD + P). AD + P affects ~50% of individuals with AD…

[HTML][HTML] Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's disease

…, C Abdelnour, M Rosende-Roca, L Vargas… - Scientific reports, 2018 - nature.com
The use of optical coherence tomography (OCT) has been suggested as a potential biomarker
for Alzheimer’s Disease based on previously reported thinning of the retinal nerve fiber …